Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC. More›

Genzyme Confirms Receipt of Unsolicited Proposal. More›

Two-Year Data from Phase 2 Trial of Genzyme’s Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal Blood. More›